Navigation Links
Study reveals rise in prostate biopsy complications and high post-procedure hospitalization rate
Date:9/21/2011

In a study of complication rates following prostate biopsy among Medicare beneficiaries, Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization. The researchers found that this common outpatient procedure, used to diagnose prostate cancer, was associated with a 6.9 percent rate of hospitalization within 30 days of biopsy compared to a 2.9 percent hospitalization rate among a control group of men who did not have a prostate biopsy. The study, which will be published in the November 2011 issue of The Journal of Urology, was posted early online.

The researchers emphasize that this new data should serve as a reminder to physicians to carefully weigh the risks and benefits of biopsy for individual patients and take all precautions to prevent infections and other complications.

The Johns Hopkins team's findings are the result of the largest analysis ever performed of Medicare records of American men age 65 and older who underwent prostate biopsies in the last two decades. They found that having a prostate biopsy makes patients more than twice as likely to need hospitalization in the immediate post-procedure period. Those hospitalized had a range of complications, such as bleeding and infection, as well as flare-ups of underlying medical conditions, such as heart failure or breathing disorders.

Overall, mortality rates in men undergoing prostate biopsies did not increase. However, men hospitalized with biopsy-related infections had a 12-fold higher risk of death compared to men who did not have a biopsy.

"Prostate biopsy is an essential procedure for detecting prostate cancers," says Edward Schaeffer, M.D., Ph.D., a Johns Hopkins urologist and oncologist and the study's senior investigator. "Coupled with appropriate screening, prostate biopsies save lives. However, it is important for men to be aware of the possible risks of prostate biopsies, which are often described as s
'/>"/>

Contact: Ellen Beth Levitt
eblevitt@jhmi.edu
410-955-5307
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Japan Reactor Fallout Reached San Francisco Bay Area: Study
2. Alzheimers disease: The first prevention study of its kind
3. Large study finds genetic overlap between schizophrenia, bipolar disorder
4. UT awarded NIH grants to study prevention and treatment of neurodegenerative and vascular diseases
5. Infant mortality linked to subsequent risk of stillbirth finds new US study
6. Cash, Luxury Goods Really Do Get People Salivating: Study
7. John Theurer Cancer Center among first clinical trial sites to join landmark MMRF study
8. MRI Can Spot Breast Cancer in High-Risk Women: Study
9. Long-term effectiveness of new family planning method shown in study
10. UCSF study identifies weakness in heart attack therapy
11. Diverticulitis Surgery More Dangerous for Older Black Patients: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... The risk of pregnancy among women using a ... more than 10 times greater over a 10-year period ... study by researchers at Yale University and UC Davis ... medical journal Contraception , the study found the ... marketed under the brand name Essure. , "This ...
(Date:4/22/2014)... release is available in German . ... important intracellular signaling molecules, but their mode of action ... of cellular function and behavior, while at high concentrations ... and DNA. To analyze how redox signaling unfolds in ... microscopy technique has been developed jointly by the teams ...
(Date:4/22/2014)... Nearly 7 in 10 Americans support mandated ... national survey by researchers at the University of Michigan ... under the age of 18 at home, and adults ... than other adults to support universal coverage of birth ... the Journal of the American Medical Association ...
(Date:4/22/2014)... has been approved since November 2013 for the prevention ... In an early benefit assessment pursuant to the "Act ... (AMNOG), the German Institute for Quality and Efficiency in ... offers an added benefit over the appropriate comparator therapy. ... of turoctocog alfa is not proven. As no relevant ...
(Date:4/22/2014)... intervention researchers have been informed that the National Institute ... Institutes of Health, will award an $8 million grant ... an experimental drug for stroke. , The drug, ... plasminogen activator, or rtPA the "clot-busting" drug currently ... laboratory rodent studies, 3K3A-APC, used in combination with rtPA, ...
Breaking Medicine News(10 mins):Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3Health News:Neuroimaging: Live from inside the cell 2Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 2Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 3Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3
... of a multi-faceted transcriptional complex to control of ... stem cells. Two separate studies, published by Cell ... Cell, provide insight into novel subunits associated with ... a previously undescribed chromatin function that is required ...
... M.D., Will Lead One of the Nation,s Largest ... Electrophysiology Programs, ... and Director of Cardiac Electrophysiology at,Washington University in St. Louis, has ... Institute., "We are pleased to have such an established leader ...
... largest,provider of business services to orthodontic and dental ... and Atlanta, Georgia to,better serve the company,s practices ... confirm our operating principle that the,heart of our ... in the,hundreds of practices we serve each day," ...
... 11% of international disease burden , , THURSDAY, Jan. 17 ... childhood malnutrition accounts for more than one-third of childhood ... researchers report. , "The key messages here are that ... reform is needed," lead researcher Dr. Robert Black, a ...
... adopt the World Health Organization (WHO) standard on fine particulate ... premature deaths, concludes research in the Journal of Epidemiology and ... levels of fine particulate matter pollution (PM2.5) at 20 g/m ... by the US Environmental Protection Agency is 15 g/m ...
... London, New Delhi and Singapore (January 17, 2008) ... looks set to continue its successful growth in ... partnership with the International Union for Health Promotion ... Promotion & Education. , Published quarterly, Promotion and ...
Cached Medicine News:Health News:Cancer stem cell marker also drives transcription in normal cells 2Health News:Cancer stem cell marker also drives transcription in normal cells 3Health News:Cleveland Clinic Recruits World Renowned Heart Rhythm Specialist to Direct Electrophysiology 2Health News:OrthoSynetics(TM) Opens Regional Offices in Dallas, Atlanta 2Health News:Malnutrition Responsible for a Third of Child Deaths Worldwide 2Health News:Malnutrition Responsible for a Third of Child Deaths Worldwide 3Health News:Europe should adopt WHO recommendations for particulate matter cuts 2
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ...
(Date:1/15/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ... by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), ... of Solta Medical, Inc. (NASDAQ: SLTM ) ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... Morria Biopharmaceuticals Plc, a,biopharmaceutical company focused ... announced that it has obtained regulatory,approval from ... to initiate,a Phase II study of MRX-4 ... The two-arm, randomized, multi-dose, double-blind, placebo-controlled,study includes ...
... Md., June 11 EntreMed, Inc.,(Nasdaq: ENMD ... treatment of cancer and inflammatory diseases, today,announced the ... of 2-,methoxyestradiol (2ME2). The patent grants EntreMed composition-of-matter,and ... for analogs,of 2ME2 in oncology and a broad ...
Cached Medicine Technology:Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis 2EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 2EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: